0
Arvinas Banner Image

Arvinas

  • Ticker ARVN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arvinas Logo Image
  • 201-500 Employees
  • Based in New Haven, Connecticut
Arvinas is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses its proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC™ protein degraders, that are designedMore to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Arvinas

Most Recent Annual Report

Arvinas
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports